CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 186 filers reported holding CHEMOCENTRYX INC in Q2 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $520,000 | +111.4% | 10,074 | +1.5% | 0.21% | +127.5% |
| Q2 2022 | $246,000 | -12.5% | 9,930 | -11.4% | 0.09% | -27.8% |
| Q1 2022 | $281,000 | -31.1% | 11,214 | 0.0% | 0.13% | -18.2% |
| Q4 2021 | $408,000 | +47.8% | 11,214 | -30.5% | 0.15% | +27.3% |
| Q3 2021 | $276,000 | +21.6% | 16,142 | -5.0% | 0.12% | +30.1% |
| Q2 2021 | $227,000 | -7.0% | 16,985 | +256.2% | 0.09% | -9.7% |
| Q1 2021 | $244,000 | -16.2% | 4,769 | +1.6% | 0.10% | -14.9% |
| Q4 2020 | $291,000 | +12.4% | 4,694 | -0.8% | 0.12% | -11.0% |
| Q3 2020 | $259,000 | -16.5% | 4,732 | -12.1% | 0.14% | -7.5% |
| Q2 2020 | $310,000 | -32.6% | 5,386 | -52.9% | 0.15% | -22.2% |
| Q1 2020 | $460,000 | -11.4% | 11,447 | -12.7% | 0.19% | +122.4% |
| Q4 2019 | $519,000 | +153.2% | 13,115 | -56.7% | 0.08% | +107.3% |
| Q3 2019 | $205,000 | -31.0% | 30,286 | -5.3% | 0.04% | -34.9% |
| Q2 2019 | $297,000 | -19.1% | 31,973 | +20.9% | 0.06% | -91.9% |
| Q1 2019 | $367,000 | +13.3% | 26,452 | -10.8% | 0.78% | +1320.0% |
| Q4 2018 | $324,000 | -30.3% | 29,652 | -19.4% | 0.06% | +14.6% |
| Q3 2018 | $465,000 | -44.7% | 36,802 | -42.3% | 0.05% | -93.5% |
| Q2 2018 | $841,000 | – | 63,829 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
| Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
| HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
| Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
| Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
| Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
| Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
| Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
| Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |